Seza A Gulec
Overview
Explore the profile of Seza A Gulec including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
741
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McGoron A, Garcia J, Uluvar B, Gulec S
Endocr Oncol
. 2025 Feb;
5(1):e240072.
PMID: 39968056
Radioactive iodine (RAI) treatment is an established therapeutic tool for 'differentiated thyroid cancers'. The therapeutic effectiveness is linked to the preservation of the iodine-concentrating ability of the neoplastic tissue, a...
2.
Wang K, Gulec S
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685923
Thyroidectomy has been post-operatively managed by hormone replacement therapy in order to satisfy the reference ranges of thyroid stimulating hormone (TSH) and thyroxine (T4) levels. While medication and standardized reference...
3.
Gulec S, Benites C, Cabanillas M
J Clin Med
. 2024 Jul;
13(13).
PMID: 38999211
Thyroid cancer molecular oncogenesis involves functional dedifferentiation. The initiating genomic alterations primarily affect the MAPK pathway signal transduction and generate an enhanced ERK output, which in turn results in suppression...
4.
Gulec S, Meneses E
Cancers (Basel)
. 2024 Apr;
16(8).
PMID: 38672667
Theranostics define diagnostic evaluations directing patient-specific therapeutic decisions. Molecular theranostics involves genomic, transcriptomic, proteomic, metabolomic and finally phenonic definitions thyroid cancer differentiation. It is the functional differentiation that determines the...
5.
Chiosea S, Hodak S, Yip L, Abraham D, Baldwin C, Baloch Z, et al.
J Clin Endocrinol Metab
. 2023 Apr;
108(11):2999-3008.
PMID: 37071871
Context: Comprehensive genomic analysis of thyroid nodules for multiple classes of molecular alterations detected in a large series of fine needle aspiration (FNA) samples has not been reported. Objective: To...
6.
Gulec S, McGoron A
N Engl J Med
. 2022 Jun;
386(22):2154-2155.
PMID: 35648716
No abstract available.
7.
Gulec S, McGoron A
Semin Nucl Med
. 2022 Feb;
52(2):215-228.
PMID: 35148897
Radiomicrosphere Therapy (RMT) refers to a liver-directed therapeutic modality based on the intrahepatic arterial administration of radiolabeled microspheres. There is a need for standardization of the terminology of RMT. A...
8.
Ehrhardt Jr J, Gulec S
Am Surg
. 2022 Jan;
89(5):2145-2149.
PMID: 35081787
This is the story of how one man's life's work allowed for Iodine-131 (I-131) to become a therapy for hyperthyroidism and thyroid cancer. What is now a standard in our...
9.
Gulec S, Ahuja S, Avram A, Bernet V, Bourguet P, Draganescu C, et al.
Thyroid
. 2021 Apr;
31(7):1009-1019.
PMID: 33789450
The American Thyroid Association (ATA), the European Association of Nuclear Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and Molecular Imaging have established an intersocietal working group...
10.
Han S, Ehrhardt Jr J, Shukla S, Elkbuli A, Nikiforov Y, Gulec S
Am J Case Rep
. 2019 Jul;
20:1027-1034.
PMID: 31308356
BACKGROUND Theranostics is a combined diagnostic and treatment approach to individualized patient care. Kostmann syndrome, or severe congenital neutropenia, is an autosomal recessive disease that affects the production of neutrophils....